[Septic-toxic shock due to rhabdomyolysis in a patient treated with fenofibrate].
Lipid disorders have been treated with fibrates for many years. Rhabdomyolysis is one of the side effects of these drugs. We report a case of a septic-toxic shock due to rhabdomyolysis in a 75-year old patient, who had been treated with fenofibrate for 2 years. This case shows necessity of the standard monitoring of aminotransferase, phosphocreatine kinase and creatinine levels during treatment with fibrates.
Duda-Król
W
W
Katedry i Kliniki Chorób Wewnetrznych i Hematologii Akademii Medycznej w Warszawie.
Jórasz
I
I
Dabrowska
M
M
Polubiec
A
A
Kusz-Rynkun
A
A
D000368:Aged; D003402:Creatine Kinase / Q000097:blood; D003404:Creatinine / Q000097:blood; D005260:Female; D011345:Fenofibrate / Q000009:adverse effects*; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000009:adverse effects*; D010725:Phosphocreatine / Q000097:blood; D012206:Rhabdomyolysis / Q000139:chemically induced* / Q000150:complications*; D012772:Shock, Septic / Q000188:drug therapy* / Q000209:etiology*; D000637:Transaminases / Q000097:blood
D000960:Hypolipidemic Agents; D010725:Phosphocreatine; D003404:Creatinine; D000637:Transaminases; D003402:Creatine Kinase; D011345:Fenofibrate